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Significant controversy has existed in the areas of 
management of women with cervical cytological diagnoses of 
atypical squamous cells of undetermined significance (ASCUS) 
and ASCUS suggestive of human papillomavirus (HPV). The 
purpose of this study was to determine the incidence of 
cervical dysplasia in women with and without cytology 
suggestive of HPV in order to improve patient management.
The Bethesda System was utilized as the basis for a 
conceptual physiological framework. Orem's self-care theory 
was shown to support the framework. The researcher 
hypothesized that there would be no difference in the 
incidence of cervical dysplasia in women with cytology 
suggestive of HPV and women without cytology suggestive of 
HPV. This retrospective study utilized a convenience sample 
(N = 58) drawn from a population consisting of records of 
women (N = 442) with cytology reported as ASCUS from an area 
in the southeastern United States. Descriptive and 
inferential statistics were employed for data analysis. 
Descriptive statistics confirmed an incidence of cervical 
dysplasia in women with ASCUS (n = 42) of 3 0.95% and an 
incidence of cervical dysplasia in women with ASCUS 
suggestive of HPV (n = 16) of 18.75%. This finding
iv
represents a 65% higher incidence of cervical dysplasia in 
the women with Pap reports of ASCUS without evidence of HPV. 
Utilizing contingency tables and chi-square analysis, no 
significant difference between the two subsets and the 
incidence of dysplasia emerged, X^(l, N = 58) = 0.8629, 
p < .05, p = 0.353. Therefore, the researcher concluded no 
difference in the incidence of cervical dysplasia in women 
with cytology reports of ASCUS and women with cytology 
reports of ASCUS suggestive of HPV existed and accepted the 
null hypothesis. Findings indicated the need for further 
research and closer monitoring of patients with cytologic 
diagnosis of ASCUS and ASCUS suggestive of HPV. Nurse 
practitioners must assume responsibility to conduct research 
in the area of ASCUS and ASCUS suggestive of HPV to extend 
theory and knowledge while functioning as primary care 
providers for women. Management of cytology reports will be 
an important component of clinical practice and involve 
intervention, educative and supportive nursing functions.
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Chapter I 
The Research Problem 
Significant controversy has existed in the areas of 
management of women with a cytological diagnosis of atypical 
squamous cells of undetermined significance (ASCUS) (ACOG 
Technical Bulletin, 1993; Schaffer & Philput, 1992; Slawson, 
Bennett, & Herman, 1993) and women with the diagnosis of 
ASCUS suggestive of human papillomavirus (HPV) (American 
College of Obstetricians and Gynecologists, 1994; Kurman, 
Henson, Herbst, Noller, & Schiffman, 1994; Schaffer & 
Philput, 1992). Gaining additional knowledge regarding the 
incidence of progression of ASCUS to cervical dysplasia will 
have provided more direction in the management of women with 
ASCUS and ASCUS suggestive of HPV. The purpose of this study 
was to determine the incidence of cervical dysplasia in 
women with and without cytology suggestive of HPV in order 
to provide improved and appropriate management to women with 
ASCUS.
Further controversy has existed in the area of cervical 
cytology. While the Papanicolaou (Pap) smear has remained 
the most successful screening tool for cervical cell 
abnormalities, refinements in diagnosing cervical cytology 
have continued. Terminology used to define gradations of
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cervical disease, classifications to describe test results, 
and appropriate techniques for collecting adequate cervical 
cell specimens have been targeted for change (Fowler, 1993). 
The Bethesda System has remained the accepted standard for 
cervical cytology diagnosis since the early 1990's.
Establishment of the Problem
One of the major classifications of The Bethesda System
scrutinized has been that of atypical squamous cells of
undetermined significance (ASCUS). Kurman and Solomon (1994)
indicated ASCUS results reflected either an exuberant benign
change or a potentially serious lesion, and, therefore, were
interpreted to be of undetermined significance. Abdul-Karim
and Willis (1994) reported numerous studies attempted to
determine the biological significance of atypical squamous
cells without much consistency.
The available data indicate that for many specimens demonstrating ASCUS, patients do not have a significant lesion, and follow-up smears or colposcopic biopsies are normal. In a proportion of patients, however, the abnormality will persist and in a significant number of these, further 
evaluation will detect a squamous intraepithélial lesion. (Kurman & Solomon, 1994, p. 42)
Significant controversy has existed in the management 
of women with ASCUS. Guidelines for management established 
by the American College of Obstetricians and Gynecologists 
(ACOG) were presented in the ACOG Technical Bulletin of 
August 1993. If the patient with cytological diagnosis of 
ASCUS was determined to be reliable, she could be scheduled 
to return for repeat Pap smears every six months.
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Recommendation was for colposcopic examination after two or 
more cervical cytology reports of ASCUS. With a potentially 
non-compliant patient, initial colposcopy was recommended 
for consideration. Conversely, Schaffer and Philput (1992) 
suggested a decision for management be based on the 
patient's resources and history while Slawson, Bennett, and 
Herman (1993) recommended immediate colposcopy for atypical 
smears.
Another dilemma was the diagnosis of ASCUS suggestive 
of human papillomavirus (HPV) on cervical cytology smears. 
HPV has been recognized as being highly prevalent in the 
general population and spread through sexual contact 
(Morrison, 1994). The possibility of HPV opened a whole new 
arena for exploration. Of initial importance was, according 
to Dr. V. Cecil Wright, the latency period of HPV after 
exposure which may range from six weeks to twenty years 
(personal communication, December 4, 1994). In 1992,
Schaffer and Philput reported there was no documentation of 
the risk of latent HPV progression over time. Even so, ACOG
(1993) reported that women with HPV were at increased risk 
for preinvasive cervical lesions. ACOG also reported that a 
progression to high grade squamous intraepithélial lesion 
(SIL) occurred in approximately 15% of women with HPV and 
that spontaneous regression occurred in approximately 60%. 
ACOG did not propose the outcomes of the other approximate 
25%. High rates of false negative results have indicated the
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need for histologic confirmation. Low grade SIL, which 
included HPV, and ASCUS classifications represented, 
according to Kurman, Henson, Herbst, Noller, and Schiffman
(1994), the greatest problem for the clinician from the 
standpoint of management and the largest volume of patients 
that required evaluation. Not surprisingly, controversy over 
management of these findings also has existed.
ASCUS suggestive of HPV had cytologic changes that when 
observed could possibly have been related to the type of HPV 
infection. Thus colposcopic examination proved helpful in 
the increased rate of detection of HPV. Management of ASCUS 
suggestive of HPV, however, and controversies surrounding 
the diagnosis, remained similar to those of ASCUS (Abdul- 
Karim & Willis, 1994).
There has been substantial controversy in the 
management of women with atypical squamous cells because of 
the identification of undetermined significance. Some 
literature suggested practitioners watch and wait while 
others supported an aggressive approach which utilized 
immediate colposcopy for diagnostic determination. Kline and 
Kannan (1994) indicated the need to further study the 
biologic behavior of ASCUS. Due to frequent changes in 
cytology reporting, inconsistencies between reportings, and 
lack of current literature, further investigation was 
necessary.
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Significance to Nursing 
As the incidence of cervical dysplasia in women with 
and without cytology suggestive of HPV has been quantified, 
additional information has been added to the body of 
existing knowledge in nursing as well as other medical 
fields. Research, along with improved and consistent 
management of women with ASCUS, has strengthened not only 
the role of the nurse practitioner, but has also contributed 
to the current body of scientific research in the areas of 
ASCUS and ASCUS suggestive of HPV. This study quantified the 
incidence of cervical dysplasia and therefore has 
strengthened the support for specific guidelines for 
management of patients with cervical cytologic ASCUS 
classification. Nurse practitioners have the responsibility 
to provide supportive and educative services to their 
clients. This research will benefit practitioners' services 
by strengthening the scientific body of knowledge in 
management of women with Pap smear reports of ASCUS and 
ASCUS suggestive of HPV by determining the incidence of 
subsequent cervical dysplasia. Not only compliance but 
timely follow-up has been indicated to optimize the outcomes 
of these patients. As nurse practitioners' roles expand in 
the primary care arena, nurse practitioners must assume 




The Bethesda System served as the basic physiological 
framework of this research to facilitate the 
conceptualization of the study and support the contributing 
information. Dorothea Orem's self-care theory supported 
women's measures in obtaining cervical screening and follow- 
up as well as the nurse practitioner role in their 
management.
The Bethesda System was adopted in December 1988 to 
promote communication between the laboratory and the 
clinician by providing uniform diagnostic terminology. The 
design of The Bethesda System was to facilitate 
categorization and reporting of cytologic diagnoses. The 
cytologic diagnosis was based on the most abnormal cells 
present on a smear (Kurman & Solomon, 1994) (see Appendix A 
for the complete Bethesda System).
The Bethesda System was amended and modified in April 
1991. It was emphasized that The Bethesda System was only a 
recommended terminology not specifically mandated by 
legislation. Use of traditional terminology was still 
acceptable for use in conjunction with The Bethesda System 
(see Appendix B for terminology comparisons between 
classification systems). The predominant strength of The 
Bethesda System identified by Fowler was the use of 
terminology that closely followed the histopathologic
7
vocabulary utilized in reporting cervical cytologic 
diagnoses (Valente & Shantz, 1993).
Specimen adequacy held high priority at the second 
Bethesda conference held in 1991. Specimen adequacy was 
correlated to collection of both squamous epithelium cells 
and squamous metaplastic cells. Columnar and squamous 
epithelium comprise the cervix. The cervical transformation 
zone, an area of change, was identified as an area of 
squamous metaplasia. Squamous metaplasia was defined as the 
process by which columnar cells evolve into squamous cells, 
and mature squamous epithelium occurs when the tips of 
columnar papillae grow together (Rubin & Lauver, 1990). A 
fully satisfactory Pap smear included cell samples of 
squamous epithelium cells and squamous metaplastic cells and 
was correlated with specimen adequacy. The cells were most 
easily sampled using a Cytobrush and Ayre wooden spatula.
The Pap smear was not promoted as a diagnostic tool, but 
specificity was reported to be high if the results were 
positive (Buck, 1994).
Other sections of The Bethesda System included general 
categorization, which was optional, and descriptive 
diagnoses. Epithelial cell abnormalities included ASCUS. The 
Bethesda System reports had to qualify ASCUS as to whether a 
reactive or prema1ignant (suggestive of HPV) or even a 
malignant process was favored. The specimen adequacy was 
considered along with the Pap smear results. Appropriate
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management was supported based on the adequacy of the
specimen and the cervical cytology results. Management also
was aided by the consistency of reporting— the descriptive
diagnoses, and the criteria for interpretation as was
outlined in The Bethesda System (Valente & Schantz, 1993).
While the physiologic framework of this study was
developed around The Bethesda System, the theoretical
framework was developed utilizing Dorthea E. Orem's Self-
Care Deficit Theory of Nursing. Orem (1991) acknowledged her
theory as a general theory composed of three related
theories. The first was the theory of self-care in which
self-care was described and explained:
Self-care is learned, goal-oriented activity of individuals. It is behavior that exists in concrete life situations directed by persons to 
self or to the environment to regulate factors that affect their own development and functioning in the interests of life, health, or well-being.(Orem, 1991, p. 64)
Orem's second theory, the theory of self-care deficit,
described and explained why people can be helped through
nursing. The theory of nursing systems was Orem's third
theory. In her theory of nursing systems, Orem described and
explained relationships that must be brought about and
maintained for nursing to occur (Orem, 1991).
Orem's (1991) theory of self-care related directly to
women seeking Pap smear screening. Self-care requisites
fostered health and well-being. The role of the nurse
practitioner in providing information and explanations to
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facilitate knowledge of an illness or potential illness 
fostered competency in the women to manage an illness. The 
client was, more than likely, her own self-care agent— "the 
provider of self-care" (Orem, p. 117). Nurse practitioners 
enabled women desiring health promotion and disease 
prevention the ability to act as their own self-care agents. 
The nurse practitioner functioned in the nursing system by 
not only providing the screening and education that allowed 
the woman to make informed decisions, but the practitioner 
also provided some of the follow-up procedures for a 
possible abnormal Pap smear result.
In summary. The Bethesda System provided a framework in 
which to conceptualize the problem of ASCUS and HPV while 
Orem's theory of self-care provided a theoretical framework 
for the problem. The Bethesda System functioned to provide 
more consistency in the interpreting and reporting of 
cervical cytology results by use of terminology closely 
associated with surgical diagnoses. Additionally, Orem's 
theory of self-care supported women with health seeking 
behaviors and integrated the role of the nurse practitioner 
into the patient's mechanism for action.
Assumptions
For this study, the assumptions were the following:
1. For the specimens utilized in this study there was 
consistent cytology reporting over time and between 
specimens.
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2. For the specimens utilized in this study there was 
consistent tissue diagnosis over time and between specimens.
3. Women practiced activities they initiated and 
performed on their own behalf in maintaining life, health, 
and well-being.
Purpose of the Studv 
The purpose of this study was to determine the 
incidence of cervical dysplasia in women with and without 
atypical squamous cells of undetermined significance 
suggestive of human papillomavirus.
Statement of the Problem 
Significant controversy has existed among women health 
experts concerning the management of women with abnormal Pap 
smears. While some experts recommend follow-up with repeat 
pap smears (ACOG, 1993), others recommend immediate 
colposcopy (Slawson, Bennett, & Herman, 1993). ASCUS and 
ASCUS suggestive of HPV as defined by The Bethesda System 
have been the focus of much controversy. Little research has 
been published in the area of ASCUS and ASCUS suggestive of 
HPV with significant contributions to patient management. 
This study addressed the question: What is the incidence of 
cervical dysplasia in women with and without cytology 
suggestive of human papillomavirus? in order to contribute 
to the body of knowledge in clinical management of women 




The hypothesis of this research was that there is no 
difference in the incidence of cervical dysplasia in women 
with and without cytology suggestive of human 
papillomavirus.
Definition of Terms
For the purpose of this study, the following terms were 
defined:
Cervical Dvsplasia
Theoretical. Cervical dysplasia as defined by The 
Bethesda System is an abnormal differentiation in 
proliferating cells which results in an abnormal degree of 
variation in size, shape, and appearance of cells and a 
disturbance in the usual arrangement of such cells (Abrams, 
1992) .
Operational. Cervical dysplasia was considered to be 
any level of cervical dysplasia identified by surgical 
tissue (biopsy) diagnosis.
Women
Theoretical. Women are defined theoretically as female 
persons.
Operational. Women were those female persons with 
abnormal cervical cytology.
Cytology
Theoretical. Cytology is defined as microscopic 
examination of cells desquamated by means of aspiration.
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washing, smear, etc. from a body surface in order to detect 
malignancy and microbiologie changes in accordance with The 
Bethesda System (Friel, 1981).
Operational. Papanicolaou smear reports of atypical 
squamous cells of undetermined significance were the 
functional definition of cytology.
Atypical Sauamous Cells of Undetermined Significance (ASCUS) 
Theoretical. According to The Bethesda System, cells 
with abnormalities that are greater than those attributable 
to reactive changes but are quantitatively or qualitatively 
less than those abnormalities of a squamous intraepithélial 
lesion (Kurman & Solomon, 1994).
Operational. Cytology reported on a Pap smear result 
according to The Bethesda System guidelines served as the 
operational definition of ASCUS.
Atypical Sguamous Cells of Undetermined Significance (ASCUS) 
Suggestive of Human Papillomavirus (HPV)
Theoretical. ASCUS with other abnormal cells that give 
the impression that HPV may be present but are not 
identified as a definitive squamous intraepithélial lesion 
according to The Bethesda System.
Operational. For this study, ASCUS suggestive of HPV 




Controversies have existed in the area of cervical 
cytology. The Bethesda System was established to provide 
continuity and clarification of cervical cytology. The 
Bethesda System's classification of atypical squamous cells 
of undetermined significance fell under much scrutiny. No 
consistency was found in determining the biological 
significance of atypical squamous cells nor was there any 
consensus in the management of women with ASCUS or of women 
with ASCUS suggestive of human papillomavirus.
Orem's theory of self-care directed the role of nurse 
practitioners as supportive and educative systems in 
enabling women who desired health promotion and disease 
prevention to act as their own self-care agents. While Orem 
was utilized as the theoretical framework for this study.
The Bethesda System was established as the physiologic 
framework. The Bethesda System aided the conceptualization 
of the problem of ASCUS and ASCUS suggestive of HPV. The 
Bethesda System provided consistency in reporting Pap smear 
results and in the criteria for diagnostic interpretation.
Chapter II
Review of the Literature
An exhaustive search of the literature revealed a lack
of current research reports on cervical cytology diagnosis
of ASCUS and ASCUS suggestive of HPV. Only two recent
studies, one from 1993 and one from 1994, specifically
addressed the ASCUS designation from The Bethesda System.
Both studies were Harrisburg, Pennsylvania area network
(HARNET) studies.
The 1993 study was titled "Follow-up Papanicolaou Smear
for Cervical Atypia: Are We Missing Significant Disease?"
(Slawson, Bennett, & Herman). The purpose of the research
outlined in this study was to examine two objectives:
(1) the prevalence of undetected CIN [cervical intraepithélial neoplasia] among women in primary care settings with a Pap smear showing atypia of undetermined significance, and (2) the accuracy of a single follow-up Pap smear performed with an endocervical Cytobrush and a wooden spatula in identifying those women subsequently found to have 
biopsy-proven CIN (Slawson et al., p. 290).
The researchers surmised that the data on which many
investigators based their recommendations for colposcopy may
have been misleading due to the referral population of women
with identified risk factors, the method by which the Pap
smears were obtained, and the adaptation of the results to
The Bethesda System for cytological analysis. Consequently,
14
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the authors stated that the risk in women with cervical 
atypia and no evidence of HPV or dysplasia, which was 
classified as squamous atypia of undetermined significance, 
was uncertain (Slawson et al., 1993).
The design included a population of 7,458 women (N = 
7,458) that presented for an initial Pap smear in one of six 
family practice offices in the Harrisburg, Pennsylvania 
area. Major population differences between the sites were 
not identified. Each Pap smear was obtained using a 
Cytobrush and wooden spatula. All abnormal Pap smears 
identified by a cytotechnologist were reviewed by a board 
certified pathologist that had no knowledge of the study. 
Atypia of undetermined significance was identified in 442 
patients and 159 remained eligible for continuation in the 
study (n = 159). Out of this sample, 3 7 chose immediate 
colposcopy while 121 women consented to wait four to six 
months before returning for a repeat Pap smear and 
colposcopy. Colposcopic directed biopsies were performed by 
trained and certified practitioners and were reviewed by 
board certified pathologists (Slawson et al., 1993).
The prevalence rate of CIN determined by colposcopic 
directed biopsies among women whose screening Pap smears 
showed atypical cells of undetermined significance was 3 5%. 
Single follow-up Pap smears had a false negative rate of 
57%. One third of the high grade lesions were not identified 
by Pap smears (Slawson et al., 1993).
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Of the women (n = 37) choosing immediate colposcopy, 15 
(40%) were identified as having CIN I and none with a more 
severe lesion. Those that waited (n = 121) had a 34% 
incidence of CIN and more significantly a 12% incidence of 
CIN II/III. These results may have indicated that 
progression of cervical disease occurred during the four to 
six month waiting period or that normal reparative healing 
was not allowed to occur in the sample that underwent 
immediate colposcopy (Slawson et al., 1993).
Based on data analysis, Slawson et al. (1993) 
recommended that all women with cervical atypia of 
undetermined significance undergo colposcopic examination. 
Repeat Pap smears were encouraged every four to six months 
for one to two years if initial colposcopic studies were 
refused. If any abnormal cytology occurred during follow-up, 
colposcopy was recommended.
One-third of the women in this study with cervical 
atypia on an initial Pap smear had CIN after cervical 
biopsy. The Pap smear obtained failed to detect one—half of 
the cases of biopsy-proven CIN. Slawson et al. (1993) 
recommended further studies regarding the use of 
supplementary screening methods. In comparison with The 
Bethesda System, CIN corresponded to low grade and high 
grade squamous intraepithélial lesions. These results 
indicated a need for further study and the current study 
pursued the meaning of ASCUS in another setting.
17
Slawson, Bennett, Simon, and Herman (1994) published 
another study titled "Should All Women With Cervical Atypia 
Be Referred for Colposcopy: A HARNET Study. The purpose of 
the research was to determine the optimal management of 
women whose Papanicolaou (Pap) smears showed atypical 
squamous cells of undetermined significance (ASCUS). In the 
previous HARNET study, it was concluded that a Pap smear 
follow-up four to six months later failed to accurately 
predict abnormal colposcopic biopsies. Therefore, additional 
tests to augment the follow-up Pap smear were evaluated 
which included a human papillomavirus (HPV) screen and a 
naked eye examination after a five percent cervical acetic 
acid wash (Slawson et al., 1994).
Initial Pap smears were performed on 7458 women who 
attended six Harrisburg, Pennsylvania area family clinics. 
The population was from urban, suburban, and semirural 
areas. ASCUS was found on 442 Pap smears (N = 442). 
Consenting subjects (n = 122) waited four to six months then 
returned for follow-up. A repeat Pap smear was performed and 
was augmented by HPV screen (ViraPap), and naked eye 
examination of the cervix after a five percent acetic acid 
wash before colposcopic directed biopsies and endocervical 
curettage (Slawson et al., 1994).
Augmenting the follow-up Pap smear with the acetic acid 
wash predicted 73% of the abnormal colposcopic biopsies. Use 
of the ViraPap had no additional effect. When identifying
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all grades of cervical lesions, the negative predictive 
value was low, but with respect to high grade lesions, 93% 
were detected. The Pap smear alone failed to detect one 
third of the high grade lesions (Slawson et al., 1994).
Findings from the second HARNET study were that (1) 
among women with cervical atypia, one-third of the cases of 
high-grade disease went undetected with a single follow-up 
Pap smear and (2) detection increased with a follow-up Pap 
smear plus an acetic acid wash. The implication presented by 
the researchers for practice was that the combined use of a 
Pap smear and an acetic acid wash would reliably guide 
clinical management of cervical atypia. Slawson et al.
(1994) recommended further research of additional screening 
methods that might improve reliability for identifying CIN 
in women with cervical atypia. Randomized controlled trials 
comparing cost-effectiveness and prevention of cervical 
cancer were recommended. Determining the incidence of 
cervical dysplasia in women with ASCUS in an area in which 
collection and interpretation of Pap smears and tissue 
specimens are consistent, as attempted in this current 
study, may prove cost-effective with clearer indications for 
follow-up recommended for cervical atypia.
Soutter, Wisdom, Brough, and Monaghan (1986) addressed 
atypical Pap smears much earlier than the previous two 
studies. The purpose of the research, titled "Should 
Patients With Mild Atypia in a Cervical Smear Be Referred
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for Colposcopy?" (Soutter et al., 1986, p. 70) was 
constructed to answer this specific question. The 
researchers believed that patients who were referred for 
colposcopy because of a mildly abnormal cervical smear often 
were found to have a more severe lesion than had been 
detected on the cervical smear (Soutter et al., 1986).
The design was a retrospective survey. The population 
was identified as women who attended a colposcopy clinic at 
the Regional Gynaecological Oncology Unit (RGOU), Gateshed 
in Great Britain. Their initial abnormal cervical cytology 
had revealed atypical but not dyskaryotic (dysplastic) 
cervical cells. The cervical smear that prompted the 
referral was termed the "index smear" (Soutter et al., 
p. 70) .
Two populations were identified and samples of 
convenience were utilized. Group 1, referred to RGOU from 
July 1, 1983, to October 30, 1983, was initially comprised 
of 199 women but 10 were excluded due to pregnancy 
(N = 189). Of these, 24% were referred for cervical atypia 
(n = 45). Group 2 was identified from 22,245 computerized 
cytology records from RGOU for the year 1983. The sample 
(n = 102) was reduced from 1,515 women with cervical atypia 
(N = 1,515) due to a varied rate of follow-up, default by 
some, and the burden of performing colposcopy on all. 
Additionally, the sample of women (n = 102) recently had 
their first abnormal Pap smears which indicated
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cervical atypia.
These women were matched for age with the year's population of women with atypical smears, and were chosen so that at least 6 months had elapsed since the initial atypical smear had been reported to allow time for follow-up data to have been obtained. (Soutter et al., 1986, p. 71)
Instrumentation included cervical smears performed on all
women in each sample followed by colposcopically directed
biopsies of any areas of atypical epithelium. If more than
one biopsy was taken from an individual, the most severe
diagnosis was used. If a cervical conization was indicated,
the patient was referred back to her physician for surgery
(Soutter et al., 1986).
Descriptive analyses of data reported 37% to 39% of
women in the first group with cervical atypia had final
diagnoses of CIN II (moderate dysplasia) or worse. Within
the second group, 27 patients were lost to follow-up, 56 had
a normal cervical smear and did not undergo colposcopy, and
9 had another abnormal cervical smear but a histological
diagnosis was not obtained. The remaining 10 women did
undergo colposcopically directed biopsies. One was diagnosed
with CIN I, three with CIN II, and six with CIN III (Soutter
et al., 1986).
Soutter et al. (1986) concluded that women with even
mildly atypical or dyskaryotic smears were at considerable
risk of having CIN. The authors recognized that most
colposcopy clinics in Britain were unable to cope with the
increased load of colposcopies for women with only one
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atypical cervical smear. Therefore, recommendation was for 
colposcopy referrals for any degree of dysplasia on a 
cervical smear. Due to increased risk for CIN in patients 
with cervical atypia and inability of existing clinics to 
cope with the additional load, further recommendation was 
for a compromise which suggested a colposcopy if two smears 
taken at an interval of at least 3 months were atypical. 
Finally, a confirmatory Pap smear six months after a second 
negative Pap smear was deemed prudent (Soutter et al.,
1986) .
Following a review of current literature, findings 
warranted a need for more aggressive follow-up. If the 
findings were significant as reported, then the burden of 
prema1ignant cervical disease would seem to outweigh any 
facility burden. The most significant statistic seemed to be 
the false negative rates of Pap smears which ranged anywhere 
from 2.4% to 69%. This research attempted to determine the 
incidence of cervical dysplasia in women with cytologic 
findings of ASCUS and ASCUS suggestive of HPV. With the 
determination of such statistics, practitioners would gain 
better understanding for follow-up measures.
Information derived from Soutter et al.'s (1986) study 
is relevant. Despite the age of the study, it holds the 
implication that atypia may be more important or significant 
than anyone was aware of then and now. Atypia must be 
followed closely through current literature, experience, and
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continued research. Researchers must remain aware as 
classification systems for cervical cytology reporting are 
changed or updated. Studies are strengthened when research 
is conducted integrating current terminology.
Schaffer and Philput (1992) addressed HPV in their 
study, "Predictors of Abnormal Cervical Cytology:
Statistical Analysis of Human Papillomavirus and Cofactors". 
The purpose of the research was to "develop and compare 
cohort profiles for cervical-cytology smears done from 1977 
to 1989 at the student health center of a large southeastern 
university" (Schaffer & Philput, 1992, p. 47). Cervical 
cancer was the most common cancer in women less than 35 
years old. The Centers for Disease Control (CDC) recognized 
a 4 60% rise in the incidence of HPV between 1966 and 1981. 
The oncogenic contribution of HPV was substantiated and the 
rise of HPV was felt to correlate with the dramatic rise of 
cervical cancer. However, the numbers of women with HPV 
without cervical cancer indicated that other cofactors along 
with HPV might lead to cervical-cytology abnormalities. The 
research questions were these: "Has the incidence of 
abnormal cervical cytology changed over the study period?
Can factors associated with abnormal cervical-cytology be 
predicted by knowledge of the risk factors implicated in the 
current professional literature?" (Schaffer & Philput, p.
47). The researchers hypothesized that by identifying 
statistically significant cofactors in association with HPV,
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they could then identify those individuals at greater risk 
for abnormal cervical cytology (Schaffer & Philput, 1992).
Schaffer and Philput's research was a retrospective 
study and utilized a sample of convenience. All patient 
records at the student health center were reviewed. The 
authors identified 2,919 records (n = 2,919) out of 9,057 
women's records (N = 9,057) with at least one cervical 
cytology report done between September 1977 and May 1989. 
Those 33% met the study criterion and comprised the sample 
(Schaffer & Philput, 1992).
Schaffer developed the instrument, Cyto 4400, from a 
literature review on cervical cancer. The instrument 
included age at first sexual intercourse, cigarette smoking, 
exposure to exogenous hormones, exposure to herpes, HPV, 
Gardnerella, Chlamydia, history of a previous abnormal 
cervical cytology smear, as well as the dates and results of 
cervical cytology, specific infections present at the time 
of each smear, treatments ordered for infections, and 
whether clients were referred to a specialist, and treatment 
provided by the specialist (Schaffer & Philput, 1992).
A cervical cytology severity rating scale was used. 
Scale validity was determined by asking experts in women's 
health to rate a list of commonly used cytology terms in 
order of severity. Validity was determined to be 0.99. Some 
women had more than one cervical smear and so their severity 
scores were added and then divided by the number of cytology
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reports. This allowed comparison between women with 
different numbers of cytology reports. However, the study 
was weakened when (1) inflammation and (7) carcinoma could 
be averaged and (4) mild dysplasia was not indicative of the 
whole picture (Schaffer & Philput, 1992).
The most prevalent infections were Gardnerella, HPV, 
and Chlamydia. There was a 10.8% rate of HPV. HPV occurrence 
was significantly higher in 1987 (ANOVA, F[10, 2105] = 6.36, 
P = .0001) (Schaffer & Philput, 1992).
The 2,919 participants had 6,224 cervical smears done 
during the study time of which 34.9% were abnormal. Cervical 
cytology by year (ANOVA, F[10, 2,077] = 17.50, p = .0001) 
indicated abnormal cervical cytology and HPV infection 
peaked the same year. Chi-square analysis revealed cervical 
smears of women exposed to HPV had significantly more 
atypias and dysplasias. Additionally, women over 3 0 years 
old did not have disproportionately high cytology severity 
(Schaffer & Philput, 1992).
A stepwise regression analysis used the dependent 
variable and entered three independent variables. The 
researchers indicated that incomplete data sets were 
excluded. HPV, the year of the cervical smear, and genital 
herpes infection were the independent variables. The overall 
R squared was 10%. The stepwise regression analysis did not 
identify a significant model to predict cervical cytology 
severity (Schaffer & Philput, 1992).
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An additive effect between HPV, herpes, and smoking was 
determined by ANOVA and Duncan's multiple range test. Women 
with all three variables had mean Pap smear scores of 3.33. 
This was consistent with squamous atypia (Schaffer &
Philput, 1992).
Over the course of the study the increases in sexually 
transmitted diseases, especially HPV, coincided with the 
increase of abnormal cervical cytology . The researchers 
concluded that further study was needed because "concurrent 
increases in HPV infection and cervical-cytology severity" 
(Schaffer & Philput, 1992, p. 50) indicate an association 
between the two.
The researchers felt the stepwise regression model was 
disappointing although it was significant. Schaffer and 
Philput (1992) indicated that if the majority of cervical 
abnormalities were resultant of HPV then HPV must not have 
been detected reliably through routine Pap smear screens. 
Underdiagnosis was thought to be due to inadequate cervical 
sampling.
In conclusion, HPV and herpes at the time of the Pap 
smear were the best predictors of abnormal Pap smears. The 
addition of smoking further increased the risk for abnormal 
cytology. Practitioners were cautioned to be aware of 
significant risk for cervical cytology severity. False- 
negative screening rates in high risk women were thought to 
be reduced with more frequent cytological screening.
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Persistent inflamination of squamous koilocytotic atypias was 
indicated for additional screening; colposcopy and biopsy 
were felt to be justified to be certain that neoplasia did 
not exist (Schaffer & Philput, 1992).
Schaffer and Philput (1992) highlighted the importance 
and impact of cervical HPV infection. Their study provided a 
foundation for this researcher to investigate the suggestion 
of HPV infection on cytologic smears diagnosed as ASCUS and 
the incidence of cervical dysplasia. In an attempt to 
determine the impact of HPV, the researcher strived to 
present a greater understanding of the effects of HPV and 
management of cytological findings of the same.
In summary, there was a scarcity of literature 
regarding the incidence of cervical dysplasia in women with 
cytologic diagnosis of ASCUS with and without suggestion of 
HPV. Two HARNET studies focused on cytologic findings of 
cervical atypia. Slawson, Bennett, and Herman (199 3) 
questioned whether or not significant cervical disease was 
being missed in primary care settings with single follow-up 
Pap smears for abnormal cervical cytology classified as 
atypia. In 1994, Slawson, Bennett, Simon, and Herman 
questioned whether all women with cervical atypia should be 
referred for colposcopy. In both studies, cervical cytology 
alone failed to be reliably predictive of cervical 
pathology. The HARNET studies supported a much earlier study 
by Soutter, Wisdom, Brough, and Monaghan (1986). The earlier
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study concluded that women with even mildly atypical 
cytology results were at considerable increased risk of 
having cervical dysplasia. Human papillomavirus effects were 
addressed by Schaffer and Philput (1992). They concluded 
that women with cytological evidence of HPV required 
additional screening including colposcopy and biopsy to 
ascertain the presence of dysplasia.
None of the studies reviewed addressed the specific 
incidence of cervical dysplasia in women with cytologic 
results of ASCUS as defined by The Bethesda System and 
results of ASCUS suggestive of HPV, another The Bethesda 
System classification. Similarly, all except Schaffer and 
Philput addressed the significance of cytologic findings of 
cervical atypia although not in the context of The Bethesda 
System. Only Schaffer and Philput (1992) studied the effect 
of human papillomavirus on cervical pathology. This research 
has synthesized the results of these studies to provide a 
basis for determining the incidence of cervical dysplasia in 
women with and without ASCUS suggestive of HPV.
Chapter III 
The Method
This retrospective study, "Incidence of Cervical 
Dysplasia in Women With and Without Cytology Suggestive of 
Human Papillomavirus", was conceptualized to address the 
problem of an undetermined significance of cervical atypical 
squamous cells and an undetermined significance of cervical 
atypical squamous cells suggestive of HPV. A chart audit was 
conducted of medical records obtained from an OB/GYN 
practice. Medical records were selected for audit by an 
examination of pathology reports obtained from a local 
pathology laboratory utilized by the OB/GYN practice. 
Sampling design was one of convenience. Data were recorded 
and quantitative analysis performed.
Variables
The independent variable was cervical cytology reports 
suggestive of HPV. The dependent variable was cervical 
dysplasia as determined by histologic diagnosis. Control 
variables included the consistency of the clinicians in 
obtaining specimens of both a cytologic and histologic 
nature and the consistency of the same cytotechnologists and 
pathologists interpreting specimens. Intervening variables 
that may have affected the research included the length of
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time between collection of a specimen and when the specimen 
was fixed, knowledge obtained and utilized in collection or 
diagnosis of specimens, change in equipment utilized for 
collection or diagnosis of specimens, misdiagnosis, 
incorrect recording of results, and client variables such as
age at first intercourse, number of sexual partners, current
sexual activity or preferences, last menstrual period, birth 
control method, smoking, elapsed time before follow-up or 
biopsy, presence of other diagnosed and/or undiagnosed
cervical or vaginal infections, and age at time of ASCUS
diagnosis.
Setting. Population, and Sample 
The setting for this research was a college town in the 
southeastern United States. The town was located in a rural 
area approximately 70 miles from a large metropolitan 
center. The population of the town combined with the 
population of the campus included approximately 10,000 
females. The area medically served was approximately 49% 
Caucasian and 49% African-American. The college was 
approximately 10% African-American and approximately 85% 
Caucasian. Foreign students comprise about 5% of the college 
population. Approximately 40% of the college students were 
classified as out of state; 60% were classified as residents 
(Board of Trustees of State Institutions of Higher Learning, 
1994) .
30
For the purpose of this study, the population (N = 442) 
included cervical cytology reports of women whose Pap smears 
were reported as ASCUS or ASCUS suggestive of HPV from March 
1994 through May 1995. The sample (N = 58) included all 
medical records of women presenting to one obstetric and 
gynecologic (OB/GYN) practice for follow-up of cytology 
indicating ASCUS or ASCUS suggestive of HPV that culminated 
in colposcopically directed cervical biopsies. Two board 
certified obstetrician/gynecologists (OB/GYNs) performed 
biopsies. The Pap smears and biopsies were diagnosed by one 
pathology group which was comprised of two board certified 
pathologists and two certified cytotechnologists.
The first cytology report of ASCUS or ASCUS suggestive 
of HPV was termed the index smear. Two sample subsets were 
established based the reported presence of HPV on the index 
smear report. The first sample subset consisted of cytology 
reports of ASCUS (n = 42) while the second subset consisted 
of cytology reports of ASCUS suggestive of HPV (n = 16).
Methods of Data Collection 
Instrumentation and Procedure
Permission to conduct this study was granted by the 
Internal Review Board of Mississippi University for Women 
(see Appendix C) and also the pathologists and OB/GYNs of 
the charts reviewed. The permission form illustrated in 
Appendix D was utilized to obtain permission from the 
physicians. Names of the practices were inserted before
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presenting the forms. The forms were explained to the 
physicians and each signed appropriately. The forms remained 
in the possession of the researcher to assure anonymity.
Names of clients with cytologic diagnosis of ASCUS were 
obtained from the pathology group. The corresponding charts 
in the office of the OB/GYNs were utilized to obtain results 
of follow-up cervical biopsies. Demographic observations 
were made of the sample utilizing the Registration Slip and 
Patient Questionnaire forms which had been provided to all 
patients at the OB/GYN practice and the GYN Cytology and 
Pathology forms from the pathology laboratory (see 
Appendixes E, F, G, and H for respective forms). Not all 
information requested was given by the patient but some 
consistency in information reported was noted.
Information normally reported by patient and/or 
physicians that could be considered intervening variables 
(Schaffer & Philput, 1992), as well as demographic 
characteristics, was recorded for the purpose of sample 
description. Due to the retrospective nature of this study, 
accessible data consisted of race, year of birth, age at the 
time of the first ASCUS or ASCUS suggestive of HPV report 
and biopsy date, date of the last menstrual period preceding 
the index cytology report and preceding the biopsy, smoking, 
birth control methods, evidence of Candida, herpes simplex 
virus, bacteria, and chlamydia, pregnancy, and the number of 
previous abnormal Pap smears in the pathology laboratory
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before the biopsy. After data collection was completed, a 
set of 200 random numbers was generated using the Lotus 12 3 
©RAND function. These numbers were then assigned to 
individual cases and names were deleted to assure anonymity 
(see Appendix I for raw data).
Method of Data Analysis
Descriptive and inferential statistics were utilized 
for data analysis. The incidence of cervical dysplasia in 
women with ASCUS and the incidence of cervical dysplasia in 
women with ASCUS suggestive of HPV were reported as 
percentages of occurrences in the sample subsets. A chi- 
square analysis was utilized to determine statistical 
significance of the incidence of cervical dysplasia in the 
sample subsets at a = 0.05.
Limitations
Many limitations were encountered throughout the 
research. The first limitation was the lack of current 
published research evaluating ASCUS and ASCUS suggestive of 
HPV. The studies that did exist did not utilize The Bethesda 
System.
Along with changes in classification systems over 
recent years, changes in cervical cell collection techniques 
also occurred. This affected the generalization to and 
comparison with previous studies. Another limitation 
encountered was the potential inconsistency in adapting one 
classification system to another.
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Follow-up Pap smears were not augmented with additional 
screening techniques by the gynecologists in this study. The 
gynecologists' normal follow-up for one Pap smear result of 
ASCUS with or without suggestion of HPV was to repeat the 
Pap smear in three to six months. If the patient was 
pregnant and colposcopy indicated, follow-up was sometimes 
delayed. If the patient was not trusted to follow-up, a 
colposcopy was sometimes performed instead of a repeat Pap 
smear. False negative rates of cytologic interpretation were 
unknown.
The fact that the sample was one of convenience has 
inherent weaknesses. Neither variables nor randomization 
could be controlled. Exposure of the clinicians and clients 
to increased knowledge of HPV had to be identified as a 
potential limitation. With increased knowledge about and 
awareness of HPV by the clinicians, bias may have also 
increased. With public education, more women have identified 
themselves at increased risk for HPV and present sooner and 
more often for Pap smears than in previous years. The 
incidence of cervical dysplasia may have appeared increased 
only due to the increased presentation of those clients at 
increased risk.
In summary, the quantitative research design was 
introduced along with its relevance to this study. 
Independent and dependent variables were stated. Many 
intervening variables were outlined. Descriptions were given
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of the setting, population, and sample. Instrumentation of 
data collection was presented along with the procedures for 
data collection and recording. The methods of data analysis 
requiring calculations of percentages and a chi-square value 
were presented. Limitations were acknowledged as affecting 
the outcome of the research.
Chapter IV 
The Findings 
The purpose of this study was to determine the 
incidence of cervical dysplasia in women with and without 
atypical squamous cells of undetermined significance (ASCUS) 
suggestive of human papillomavirus (HPV). This retrospective 
study addressed the problem of an undetermined significance 
of cervical atypical squamous cells and ASCUS suggestive of 
HPV. Sampling was one of convenience. Chart audits were 
performed on medical records from an OB/GYN group for the 
purpose of data collection and quantitative analysis.
Description of the Sample 
The sample was derived from a population of Pap smear 
reports of ASCUS by the pathology laboratory. From the list 
of 442 Pap smear reports of ASCUS and ASCUS suggestive of 
HPV (N = 442), 58 smears culminated in biopsies. Those Pap 
smears that culminated in cervical biopsies comprised the 
sample set (N = 58) and were the focus of this study.
The 58 cases in the sample set were selected on the 
basis of several criteria. First, the subjects must have had 
a Pap smear and/or biopsy within the time frame of the 
study, March of 1994 through May of 1995. Second, an index 
smear reporting ASCUS or ASCUS suggestive of HPV must have
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been satisfactory for evaluation according to The Bethesda 
System. Two subsets, ASCUS (n = 42) and ASCUS suggestive of 
HPV (n = 16), were determined by the index smear report. 
Third, the index smear must have culminated in a 
colposcopically directed cervical biopsy. Biopsies were 
performed subsequent to one abnormal Pap smear in 62.1% of 
the cases, subsequent to two abnormal smears in 36.2% of the 
cases, and subsequent to three abnormal smears in 1.7% of 
the cases. Subjects were eliminated if there was a cytology 
report of any dysplasia preceding the index smear or if 
treatment with cervical cryotherapy, conization, or laser 
vaporization was noted.
One Asian, 16 African Americans, and 41 Caucasians were 
identified during chart audits of the sample (N = 58). Ages 
reported on index Pap smears ranged from 17 to 53 years. 
Figure 1 illustrates the distribution of ages. A summary of 
sample demographics is presented in Table I.
Results of Data Analvsis
The null hypothesis was that there is no difference in 
the incidence of cervical dysplasia in women with and 
without cytology suggestive of human papillomavirus. Both 
descriptive and inferential statistics were utilized for 
analysis of sample data. Descriptive results indicated an 
incidence of cervical dysplasia in women with ASCUS (n = 42) 
of 3 0.95%, and an incidence of cervical dysplasia in women 
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ASCUS (n = 42)
f %
ASCUS Suggestive of HPV 
(n = 16) 
f %
Total (N = 58)
f %
RaceAfrican-American 11 26.19 5 31.25 16 27.59Asian 0 1 6. 25 1 1.72Caucasian 31 73.81 10 62 . 50 41 70. 69
Smoker 9 21.43 7 43.75 16 27.59
Birth Control MethodOral contraceptives 20 47.62 10 62.50 30 51.72
Tubal sterilization 6 14.29 1 6.25 7 12.07Natura1/rhythm 0 1 6.25 1 1.72Diaphragm 0 1 6.25 1 1.72Condoms 3 7.14 1 6.25 4 6.90Norplant 1 2.38 0 1 1.72None/unknown 9 21.43 2 12.50 11 18.97
Post-menopausal 3 7.14 0 3 5.17
Pregnant 3 7.14 0 3 5.17
Infection on cytologyCandida 6 14.29 2 12.50 8 13.79Herpes Simplex Virus 2 4.76 0 2 3.45Bacteria 5 11.90 1 6.25 6 10.34Chlamydia 1 2.38 0 1 1.72
represents a 12.2% point difference between the two subsets 
and a 65% higher incidence rate of cervical dysplasia in the 
women with Pap smear reports of ASCUS without evidence of 
HPV. Table II further illustrates these findings. Subjecting 
data to analysis utilizing contingency table and chi-square
39
statistics revealed X^(l, N = 58) = 0.8629, p <.05, 
E = 0.353.
Table II
Women with ASCUS Suaaestive of HPV
Cervical No cervical (n)Cytologic diagnosis dysplasia dysplasia Total
ASCUS 13 29 42
30.95% 69.05% 100%
ASCUS suggestive of HPV 3 13 16
18.75% 81.25% 100%
Using subsets of cytology reports of ASCUS (n = 42) 
and ASCUS suggestive of HPV (n = 16) and the frequency of 
dysplasia and no dysplasia on biopsy, a chi-square value 
with one degree of freedom was derived. The chi-square value 
obtained was 0.8629. This represents a probability value of
0.353 or approximately a 35% chance that a distribution of 
observations exists that would be more likely to show a 
dependency, or relationship, between cytological diagnosis 
of HPV and biopsy proven cervical dysplasia. Therefore, 
using the chi-square results, the null hypothesis cannot be 
rejected at a level of a = .05. Table III further 
illustrates these results.
Additional Findings 
Many additional findings surfaced during collection and 
analysis of the data from chart audits. Of the biopsies
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Table III
Contingency Table and Chi-Sauare Results for Cervical 
Dvsplasia bv HPV on Cvtologv
No HPV HPV Total












Total FrequencyPercentage 4272.41 1627.59 58 100.00
Note. Chi-Square Value with 1 df = 0.864, p = 0.353. Chi-Square rejection value with 1 df at a = 0.05 is 3.71.
(N = 58), 74.14% or 43 biopsies confirmed dysplasia and/or
HPV. Dysplasia was recorded on 16, or 27.59%, of the
pathology reports, and of these 16 reports, 14 also recorded
HPV. HPV without dysplasia was recorded in 2 8 cases or
48.27% of the pathology reports. A total of 42 pathology
reports indicated HPV (72.4%).
While 16 index smears had cytology consistent with
ASCUS suggestive of HPV, only 11 of them confirmed HPV by
biopsy. No pathological diagnosis of HPV was given on five
reports. Mild dysplasia was diagnosed in three of these 16
biopsies; of these three, two were also diagnosed with HPV.
Only one of these observations indicated no HPV on cytology
yet diagnosed dysplasia on biopsy.
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HPV was not noted in 42 of the index cytology reports. 
In this subset (n = 42), HPV was diagnosed by biopsy in 31 
of those observations while 13 reports of dysplasia were 
noted. There was only one observation in which dysplasia was 
diagnosed without HPV. Biopsies revealed 19 observations of 
HPV without dysplasia. Twelve of the 42 reports of ASCUS 
without evidence of HPV culminated in biopsies with 
diagnoses of both dysplasia and HPV.
Out of the 58 biopsy reports, three revealed high grade 
dysplasia— approximately 5% of the total sample. Chart 
audits of these three revealed all to be Caucasian and oral 
contraceptive users 21, 28, and 3 0 years of age. Two were 
smokers, and none had index cytology suggestive of HPV. All 
histopathology indicated HPV along with high grade 
dysplasia. Elapsed times between the index smear and biopsy 
were 175 days, 187 days, and 229 days. The mean elapsed time 
was 197 days for these three observations.
Elapsed time (Schaffer & Philput, 1992; ACOG, 1993) 
from date of index smear to date of biopsy ranged from 0—  
that is, the biopsy was done immediately following the index 
Pap smear, to 517 days. The mean elapsed time from the date 
of the index Pap smear to the biopsy date was 143.67 days 
for the sample (N = 58). Pap smears reporting ASCUS (n = 42) 
had a mean elapsed time of 148.2 days prior to biopsy. 
Reports of ASCUS suggestive of HPV (n = 16) had a mean 
elapsed time of 131.7 days prior to biopsy. The mean elapsed
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time was 140.7 days for smears that culminated in biopsy 
proven dysplasia and 144.5 days for cytology that culminated 
in HPV. Four of the observations that culminated in biopsies 
identifying cervical dysplasia had elapsed times of 35 days 
or less.
Chart audits also revealed four clients used condoms 
for birth control. Of those four, all had pathology reports 
of HPV. Three of the pathology reports also diagnosed mild 
dysplasia.
Eight index Pap smears revealed Candida. Two of these 
also suggested HPV while only one of the two had a HPV 
diagnosis from biopsy. HPV was diagnosed from biopsies of 
three of the index smears that revealed Candida without HPV. 
Only one index Pap smear that reported Candida culminated in 
a biopsy with dysplasia without HPV while the cytology 
report also gave no evidence of HPV.
Summarv
In summary, the null hypothesis, there is no difference 
in the incidence of cervical dysplasia in women with and 
without cytology suggestive of HPV, failed to be rejected 
based on inferential analysis with a chi-square value,
X^(l, N = 58) = 0.8629, p <.05, p = 0.353. However, 
descriptive statistics revealed an increase of 65% in the 
incidence of cervical dysplasia in cases of women without 
evidence of HPV as reported on the index Pap smear over 
cases with evidence of HPV as noted on the index cytology
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report. The descriptive statistics along with the chi-square 
analysis does seem to indicate a relationship although weak 
and statistically non-significant. Additional findings from 
chart audits have been presented. The findings reveal 




Notable controversy has existed in the areas of 
management of women with a cytological diagnosis of atypical 
squamous cells of undetermined significance (ASCUS) and 
women with the diagnosis of ASCUS suggestive of human 
papillomavirus (HPV). Due to frequent changes in cytology 
reporting, inconsistencies between reportings, and lack of 
current literature, further investigation into the areas of 
cervical cytology reportings of ASCUS and ASCUS suggestive 
of HPV was deemed necessary. A null hypothesis, there is no 
difference in the incidence of cervical dysplasia in women 
with and without cytology suggestive of HPV, was proposed. 
The purpose of this retrospective study was to determine the 
incidence of cervical dysplasia in women with ASCUS and in 
women with ASCUS suggestive of HPV in order to provide 
improved and appropriate management to both groups of women. 
This chapter presents a summary of the significant findings, 
additional findings, discussion, review of the physiological 
conceptual framework, conclusions, implications for nursing, 
and recommendations for further study.
A chart audit was conducted of medical records from an 
OB/GYN medical practice. Observations were made of medical 
records containing Pap smears with the diagnosis of ASCUS
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and ASCUS suggestive of HPV that had culminated in cervical 
biopsies. The setting was an area of the southeastern United 
States. The population (N = 442) included medical records of 
women with cytologic diagnosis of ASCUS and ASCUS suggestive 
of HPV made by a pathology group utilized by the OB/GYN 
group for cervical screening and diagnosis. Descriptive and 
inferential statistics were utilized for data analysis.
The null hypothesis, there is no difference in the 
incidence of cervical dysplasia in women with and without 
cytology suggestive of HPV, failed to be rejected based on 
chi-square analysis at a = 0.05. Descriptive statistics did, 
however, indicate a 65% greater incidence of HPV in women 
with cytology reports of ASCUS than in women with cytology 
reports of ASCUS suggestive of HPV. The descriptive 
statistics do highlight a possible relationship but the chi- 
square analysis indicates a weak, statistically non­
significant relationship at best. Additional findings 
revealed information pertaining to the histological 
diagnosis of HPV and dysplasia.
Summarv of Findings
The sample, N = 58, was comprised of Pap smear reports 
of ASCUS (n = 42) and ASCUS suggestive of HPV (n — 16) that 
culminated in cervical biopsies. An array of demographic 
factors was identified through chart audits.
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Significant Findings
The incidence of cervical dysplasia was found to be 
greater in women with cytology reporting ASCUS than in women 
with cytology reporting ASCUS suggestive of HPV. The 
incidence of cervical dysplasia in women with ASCUS (n = 42) 
was 30.95% while the incidence of cervical dysplasia in 
women with ASCUS suggestive of HPV (n = 16) was 18.75%.
These findings represent a 65% increase in the incidence of 
biopsy proven cervical dysplasia after index Pap smears of 
ASCUS over the incidence of cervical dysplasia after index 
Pap smears of ASCUS suggestive of HPV. Inferential analysis 
utilizing contingency tables and a chi-square value 
indicated a statistically non-significant relationship 
between the incidences of cervical dysplasia in the two 
subsets, X^(l, n = 58) = 0.8629, p < .05, p = 0.353. 
Therefore, the researcher failed to reject the null 
hypothesis at a = 0.05.
Additional Findings
While 74.14% of the cervical biopsies (N = 58) 
confirmed HPV and/or dysplasia, HPV was found to have a 
higher incidence of occurrence than dysplasia. A total of 42 
pathology reports, 72.4%, diagnosed HPV while a diagnosis of 
dysplasia was reported in only 27.59% of the sample. Of the 
subset reporting ASCUS (n = 42), 30.95% had biopsy proven 
dysplasia; of the subset reporting ASCUS suggestive of HPV 
(n == 16), 18.75% had biopsy proven dysplasia.
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Approximately 5% of the cases in the sample (N = 58) 
diagnosed high grade dysplasia. All three cases revealed 
Caucasian race and oral contraceptive users. None had 
evidence of HPV on cytology but HPV was confirmed along with 
the high grade dysplasia in each of the biopsies.
All clients reporting condom use for birth control were 
found to have HPV on biopsy. Mild dysplasia was also 
reported in 75% of those cases of HPV in condom users.
Further findings resulted from additional examination 
of demographic variables. Of the 58 cases in the sample set, 
70.69% of the women were reported to be Caucasian while 
27.59% were African Americans and 1.7% were Asian. The 
sample revealed a positively skewed bimodal distribution of 
ages. Ages ranged from 17 years to 53 years at the time of 
the index Pap smear. The mean sample age was 29.6 years. The 
mean age for the subset of reports demonstrating ASCUS was 
29.29 years and for the subset demonstrating ASCUS 
suggestive of HPV was 3 0.56 years. Smoking was reported in 
2 7.6% of the sample. Chart audits revealed 51.7% of the 
sample reported use of oral contraceptives for birth 
control.
Discussion
The researcher failed to reject the null hypothesis, 
there is no difference in the incidence of cervical 
dysplasia in women with and without cytology suggestive of 
HPV. Although inferential statistical analysis using chi-
48
square found no significant relationship in differences of 
incidences of cervical dysplasia, descriptive statistics did 
seem to indicate a relationship between cytology suggestive 
of HPV and biopsy proven dysplasia. However, the inferential 
analysis reveals this relationship to be weak and not 
statistically significant.
Utilizing descriptive statistics, a greater incidence 
of biopsy proven dysplasia with ASCUS than with ASCUS 
suggestive of HPV is noticeable. In part, this may appear so 
because there exists a morphologic overlap in cytology. 
Subjective variations between cytotechnologists and 
pathologists exist thus creating diagnostic dilemmas. The 
assumption was made, however, that within the pathology 
laboratory utilized, there would be consistency in reporting 
over time and between specimens. Some confusion does 
continue to exist in pathology in classifying ASCUS and HPV 
on cytologic smears. The need is thus demonstrated that 
ASCUS with or without evidence of HPV must be followed 
closely.
Paps reflecting ASCUS diagnoses culminated in many 
biopsy proven cases of HPV when no evidence of HPV was seen 
on the Pap smear, 31 out of 42. Again, this may be due to 
the morphologic overlap in pathology reporting. Perhaps some 
criteria was met for HPV classification on cytology but not 
all criteria was met. Results may be skewed, however, due to 
the large number of assumed sexually active college women
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having more than one partner. The local college has 
demonstrated a higher than national average in the diagnosis 
of HPV on cytology. Conversely, HPV suggested by Pap smear 
but not identified by biopsy, causes some concern. This 
inconsistency may be due in part to biopsy sampling error or 
overdiagnosis by the pathology laboratory. However, it is 
most likely due to reactive or inflammatory changes of cells 
collected for cytologic evaluation.
Some concern has existed as to whether or not the 
presence of Candida interferes with the ability to make an 
accurate cytologic diagnosis as Candida may mimic changes 
seen with ASCUS and thus lend to some overcall of ASCUS. 
Interference by Candida is not obvious from this data. The 
pathology laboratory utilized has not been steered to 
wrongful diagnoses in the presence of Candida.
Condom users in this study demonstrated a 100% biopsy 
proven HPV rate. One must take into consideration whether or 
not condoms were used consistently, and if HPV was present 
before condoms were utilized. Assuming 100% compliance, 
inference can be made that condoms are hardly protective of 
HPV transmission.
Interest and concern surface as a result of the 
diagnoses of high grade dysplasia in 5% of the sample.
Enough atypia was identified on the Pap smear that the cases 
were not lost. This, however, represents a broad spectrum of 
pathology that can be high grade but sampling on a Pap smear
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can lead to errors in diagnoses. Sampling errors may be the 
result of the size of the abnormal lesion— if the lesion is 
minuscule, there would be a decreased chance of obtaining 
those cells. The location of the lesion may not be easily 
accessible and thus may not be reached with the Cytobrush or 
Ayre wooden spatula, especially if the lesion lies within 
the glands of the cervix.
After biopsies, 74.14% of the sample (N = 58), ASCUS 
and ASCUS suggestive of HPV, demonstrated confirmed cervical 
dysplasia and/or HPV. This appears to represent a strong 
relationship between cytologic atypia and histologic atypia.
Problems with the design of the study may have affected 
the results. It was hoped that the use of one OB/GYN group 
and one pathology laboratory would strengthen the study. 
Inherent, however, is the acknowledgement that this may also 
be a theoretical shortcoming of the design. Two different 
doctors performed colposcopies, and biopsy specimens were 
interpreted by two different pathologists. Pap smears were 
interpreted by two cytotechnologists and two pathologists. 
This does not appear to be a fatal flaw, but it may account 
for some of the subjective variations in classifications. 
Another inherent limitation was the sample size and time 
frame of the study. While specific guidelines for management 
are not established, the time frame limits the inferences 
that can be drawn with respect to management. The time frame 
of this study did, however, allow for consistency in
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cytological classifications utilizing The Bethesda System. 
There will be questions as to whether or not a larger sample 
or a longer time frame would have significantly altered 
results in either the descriptive or inferential analyses. 
Also, extension of the results of this study to the general 
population may be difficult as the sample population may not 
adequately reflect the populations in other geographic 
areas.
Findings of this study lend support to most but not all 
of the current published literature. Kurman and Solomon 
(1994) indicated ASCUS results reflected either an exuberant 
benign change or a potentially serious lesion, and, 
therefore, were interpreted to be of undetermined 
significance. The sample utilized in this study, N = 58, 
revealed biopsy proven HPV and/or dysplasia in 74.14% of the 
cases. Only 25.86% of the biopsies were benign. These 
results strengthen the case for ASCUS findings representing 
potentially serious lesions.
Slawson et al. (1993) reported a 35% prevalence rate of 
biopsy proven CIN among women whose screening Pap smears 
showed ASCUS while this study revealed a prevalence rate of 
dysplasia in a subset of women whose index Pap smears showed 
ASCUS (n = 42) of 30.95% and in the total sample (N = 58) of 
27.59%. However, 74.14% of this total sample had an 
occurrence of biopsy proven dysplasia and/or HPV.
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Slawson et al. (199 3) also reported results that may 
indicate progression of cervical disease occurred during the 
four to six month waiting period after an initial ASCUS. 
Results of this study revealed a mean elapsed time from the 
index Pap smear to biopsy of 143.67 days or approximately 5 
months in which, again, a rate of 74.14% of biopsy proven 
dysplasia and/or HPV was identified. While Slawson et al. 
reported that the Pap smear alone failed to detect one third 
of the high grade lesions, this study demonstrated that none 
of the high grade lesions with HPV on biopsy were predicted 
by Pap smears and were classified as ASCUS (with no evidence 
of HPV). Thus, this study supports Slawson et al. in both 
the prevalence rate and the elapsed time measures. This 
research was even more definitive in recognizing that Pap 
smears alone may fail to detect the presence of high grade 
lesions.
Soutter et al. (1986) concluded that women with even 
mildly atypical or dyskaryotic smears were at considerable 
risk of having CIN. Despite the date of the study, the 
implication that atypia may be more important or significant 
than realized is supported by this current study. Their 
conclusions will continue to be strengthened with 
replications studies in which current terminology is 
integrated.
Schaffer and Philput (1992) found a significant chi- 
square relationship between exposure to HPV and cervical
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atypias and dysplasias on cytology. However, this research, 
while not testing for atypias, found a high percentage of 
biopsy proven HPV in women with ASCUS. While Schaffer and 
Philput concluded that women with cytological evidence of 
HPV required additional screening to ascertain the presence 
of dysplasia, the prevalence of dysplasia in this study was 
greater in the subset of reports of ASCUS than in the subset 
of reports of ASCUS suggestive of HPV.
The Bethesda System was utilized exclusively by the 
pathology laboratory in reporting cervical cytology during 
the time frame of this study. This consistency in 
classification and use of terminology closely related to 
histopathologic vocabulary strengthened this study.
Knowledge of specimen adequacy as satisfactory was utilized 
as part of the criteria for inclusion in this study as was 
the cytological classifications of The Bethesda System.
Orem's theory of self-care provided the basis for the 
assumption that women practice activities they initiate and 
perform on their own behalf in maintaining life, health, and 
well-being. With additional knowledge gained from this 
study, nurse practitioners will be able to function in the 
educative-supportive role in the nursing system to foster 
health and well-being through disease prevention and health 
promotion related to cervical cancer screening. With 
detection of abnormal cervical cytology, nurse practitioners 
will have additional knowledge to support the educative
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efforts in promoting women's understanding of the risks 
associated with any abnormal Pap smear.
Conclusions
Scarcity of current published research on the dilemma 
of diagnosis and management of women with ASCUS and ASCUS 
suggestive of HPV prompted this study. A null hypothesis was 
proposed: There is no difference in the incidence of 
cervical dysplasia in women with and without cytology 
suggestive of HPV. Descriptive statistics and inferential 
analysis suggested a weak statistically non-significant 
relationship between cytologic diagnosis of HPV and biopsy 
proven dysplasia. Thus, the researcher, using chi-square 
analysis at a rejection level of a = 0.05, failed to reject 
the null hypothesis. Findings indicate the need for further 
research and closer monitoring of patients with cytologic 
diagnosis of cervical ASCUS with or without suggestion of 
HPV.
While no previous studies have addressed this specific 
problem, some studies do parallel this research in examining 
cervical cytology reports and/or histopathology reports 
(Slawson et al., 1993; Slawson et al., 1994; Soutter et al., 
1986; Schaffer & Philput, 1992). The identified prevalence 
rate of dysplasia on cervical biopsy reports of 30.95% 
supports findings reported by Slawson et al. (1993). Elapsed 
time between the Pap smear and progression of cervical 
disease from ASCUS or ASCUS suggestive of HPV of
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approximately five months also lends support to Slawson et 
al.'s study. Five percent of seemingly mild Pap smear 
abnormalities resulted in diagnoses of high grade dysplasia 
on biopsy. This is consistent with the findings of Slawson 
et al. reported in 1994 and also with findings reported by 
Soutter et al. in 1986. The greater prevalence of HPV 
identified on cervical biopsy than on cervical cytology 
found in this research supports findings reported by 
Schaffer and Philput (1992).
While support is given to previous studies, some 
different findings also exist. The most significant 
difference, however, is the chi-square value obtained in 
this research. Analysis identified a non-significant 
relationship between the incidences of dysplasia in women 
with index Pap smear reports of ASCUS and ASCUS suggestive 
of HPV. Schaffer and Philput (1992) utilized chi-square 
statistics and determined that women exposed to HPV had 
significantly more atypias and dysplasias.
Implications for Nursing
The body of nursing knowledge has increased as a result 
of this study and the areas of research, theory, practice, 
and education have been strengthened. Validation of the 
importance of ASCUS and ASCUS suggestive of HPV through 
research helps to identify nursing actions that are within 
the realm of nursing practice and helps delineate the unique 
role of nursing in health care today. When findings from
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studies are similar, nurses will have a greater impact on 
patient outcomes. As suggested in this study, ASCUS and 
ASCUS suggestive of HPV have a much higher incidence of 
pathological changes on cervical biopsy than is indicated by 
Pap smears. Through understanding of the pathology of ASCUS 
and ASCUS suggestive of HPV, risk factors, screening, 
diagnosis and treatment, nurse practitioners can interrupt 
the spread of HPV, decrease pathogenic consequences of both 
ASCUS and HPV, and thus, avoid greater consequential 
outcomes as in the reduction of the incidence of cervical 
cancer. Nurse practitioners will also have the opportunity 
to evaluate progression or regression of cervical ASCUS and 
ASCUS suggestive of HPV. The educative effort of the nurse 
practitioner follows Orem's nursing system as does the 
intervention. If HPV is detected, counseling the infected 
woman on transmission, treatment, and prevention of 
reinfection is a large educative effort.
Nurse practitioners today are involved not only in 
counseling, education, and cervical cytology screening for 
women, but many have assumed a greater role to include 
performing colposcopies along with colposcopic directed 
biopsies. Nurse practitioners must demonstrate proficiency 
in this area in order to assure acceptance and respect by 
members of the health care profession and the communities in 
which they serve.
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Nurse practitioners have the responsibility to identify 
needs of the profession. They must remain abreast of current 
research, treatment, technology and educational issues. All 
four areas must be integrated into nurse practitioner 
curriculums to effectively prepare students for the role of 
primary care providers. Practitioners must remain aware of 
changes or updates in the classification systems for 
cervical diagnosis through networking and continued 
education.
Not only will the client and the nurse practitioner 
benefit from this study, but other health disciplines will 
also benefit as they acknowledge the integral role that 
nurse practitioners and nursing research play in today's 
health care.
Recommendations for Further Studv 
Recommendations for further study have been derived 
from lack of current published research on the importance of 
ASCUS and ASCUS suggestive of HPV. Questions have surfaced 
related to a lack of complete information and to time 
restraints. Continued research in this area will improve the 
scientific base for not only nursing practice but also the 
practice of other health professionals. Recommendations for 
further study are the following:
1. Follow-up longitudinal study on the incidence of 
cervical dysplasia in women with cytology reportings of 
ASCUS and ASCUS suggestive of HPV.
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2. Follow-up study on the incidence of cervical 
dysplasia in women with cytology reportings of ASCUS and 
ASCUS suggestive of HPV in other settings with different 
populations.
3. Follow-up study on the incidence of cervical 
dysplasia in women with cytology reportings of ASCUS and 
ASCUS suggestive of HPV with cytology sampling and cervical 
biopsies done by others and evaluation of cytology and 
histopathology by others.
4. Identification of HPV strains in this area and their 
relationship to cervical smears and biopsies.
5. Identification of demographic variables of groups of
ASCUS and groups of ASCUS suggestive of HPV and their
relationships.
6. Identification of significance of numbers of reports 
of ASCUS or ASCUS suggestive of HPV prior to biopsy and 
cervical diagnostic severity.
7. Identification of significance of elapsed time
between index smear of ASCUS and ASCUS suggestive of HPV and
the incidence of biopsy proven cervical dysplasia and/or 
HPV.
8. Correlation of cervical cytology diagnoses and 
histopathologic diagnoses with Pap smears and colposcopic 
directed biopsies performed by nurse practitioners.
9. Establishment and implementation of a colposcopy 
training program for nurse practitioners.
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10. Acceptance of nurse practitioners as primary care 
providers in women's health in Mississippi.
11. Development of a program for recording pertinent 
data that may be linked to Pap smear results and biopsies in 
order for relationships to be established.
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Appendix A The 1991 Bethesda System
The 1991 Bethesda System
Adequacy of the specimenSatisfactory for evaluation Satisfactory for evaluation but limited by (specify reason)Unsatisfactory for evaluation (specify reason)
General categorization (optional)Within normal limitsBenign cellular changes : See descriptive diagnoses Epithelial cell abnormalities: See descriptive diagnoses
Descriptive DiagnosesBenign cellular changes InfectionTrichomonas vaginalisFungal organisms morphologically consistent 
with Candida species Predominance of coccobacilla consistent with shift in vaginal flora Bacteria morphologically consistent with Actinomyces species Cellular changes associated with herpes simplex 
virus Other
Reactive ChangesReactive cellular changes associated withInflammation (includes typical response)Atrophy with inflammation ("atrophic vaginitis") 
RadiationIntrauterine contraceptive device; Other
Epithelial Cell Abnormalities Squamous cellAtypical squamous cells of undetermined 
significance : Quality^Low-grade squamous intraepithélial lesion encompassing HPV^; mild dysplasia/CIN 1 High-grade squamous intraepithélial lesionencompassing moderate and severe dysplasia, 
CIS/CIN 2, CIN 3 Squamous cell carcinoma
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Glandular CellEndometrial cells, cytologically benign, in a post-menopausal woman Atypical glandular cells of undetermined significance: Quality^Endocervical adenocarcinoma Endometrial adenocarcinoma Extrauterine adenocarcinoma Adenocarcinoma, NOS
Other Malignant Neoplasms: Specify
Hormonal Evaluation (applies to vaginal smears only)Hormonal pattern compatible with age and history 
Hormonal pattern incompatible with age and history: SpecifyHormonal evaluation not possible due to: Specify
* HPV indicates human papillomavirus; GIN, cervical intraepithélial neoplasia; CIS, carcinoma in situ; and NOS, non-organ specific.
 ̂Atypical squamous or glandular cell of undetermined significance should be further qualified, if possible, as to whether a reactive or a premalignant/malignant process is favored.
 ̂Cellular changes of HPV previously termed koilicytosis, koilocytotic atypia, or condylomatous atypia are included in the category of low-grade squamous intraepithélial lesion.
Source. The Bethesda System Committee, The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. American Journal of Surgical Patholocrv. 16,(9). 1992.
Appendix B Comparisons of Cytology Classifications
Comparisons of Cytology Classifications





I Negative n/a Within normal limits
I Negative 
(Inflammation Trich, Candida, 
Bacteria)
n/a Within normal 
limits
II Atypical cells Reactive atypia 
Atypical Repair
n/a Other - Reactive Atypia- atypical 
Repair- atypical 
Metaplasia
II Atypical cells 
(Cannot exclude 
dysplasia)










III Mild dysplasia CIN 1 with or without HPV
III Moderate
dysplasia






IV Severe CIN 3 with or without HPV






Glandular atypia - Class II or III 
Source. Adapted from Valente and Schantz, April 1993.
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Appendix C Mississippi University for Women Committee on Human Subjects in ExperimentationLetter of Approval
M ississippi 
U n iv e r s it y
FORW O M E N
Vice President for Academic Affairs 




Ms. Deanna Mackiec/o Graduate Nursing ProgramCampus
Dear Ms. Mackie:
I am pleased to inform you that the members of the Committee on Human Subjects in Experimentation have approved your proposed research with the requirement that permission to conduct the survey and to review the records be obtained from any clinics and/or M.D.'s in advance.
I wish you much success in your research.
Sincerely,,
Tlfomas C. Richardson Vice President for Academic Affairs
TR:wr
cc: Mr. Jim DavidsonDr. Mary Pat Curtis Dr. Rent
Where Excellence is a Tradition
68
Appendix DMemorandum of Agreement Concerning Research Study
Memorandum of Agreement Concerning Research Study
Title of Study:
Incidence of Cervical Dysplasia in Women With and Without Cytology Suggestive of HPV
Name of Practice:
Study discussed with and explained to;






Appendix E Registration Slip





Your Social Security Number_ 
Your Employer_______________
Your Occupation
Your Date of Birth
(City)





Your next of kin (other than husband) and relationship to you_________
This relative's address____________________________ Their phone number
Who referred you to our doctors? (Please specify)_____________________
(Zip Code
INSURANCE INFORMATION **If you have an insurance card, please Let the receptionist copy it
Primary Insurance





Insured's Social Security i_ 
Policy or ID <
Croup Number/Name__________
Insured's Social Security f
Policy or ID ÿ_____________
Group Number/Name__________
Benefits Phone Number 
Pre-cert Phone Number_ 
Mail Claims To:
Benefits Phone Number 
Pre-cert Phone Number_ 
Mail Claims To:
ASSIGNMENT OF BENEFITS/AUTHORIZATION TO RELEASE INFORMATION: I hereby authorize payment o!
insurance benefits payable to me but not to exceed the regular charges for the current yeai 
directly to Oxford OB/GYN Associates, P.A. I understand that I am financially responsible 
to Oxford OB/GYN Associates, P.A. for charges not covered by this authorization. I hereby 
authorize Oxford OB/GYN Associates, P.A. to release medical information for the purposes oi 
filing insurance claims with my insurance company (companies).
(Patient's signature/Parent's signature, if patient is
a minor)
(Today's Date)
Billing Addressdf different from Mailing Address)
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Appendix F Patient Questionnaire
PATIENT QUESTIONNAIRE
Name________________________________________________________________________Date______________________
During the last year, your life may have changed and this may affect your health. Please help us to provide the best health 
care for you by completing this short questionnaire.
Circle one If yes, please specify
Have you changed your occupation?  Yes No __________________________________
Do you have any problems at home?    Yes No __________________________________
Has there been any change in your relationship
with your husband, partner, or boyfriend?  Yes No __________________________________
Has there been a change in your periods?  Yes No __________________________________
Date of your last period?_________________
Do you use a method of contraception?   Yes No Do you use it regularly?_____________
If yes, what type? pills lUD diaphragm condoms Are you/your partner satisfied with this
natural/rhythm sponge spermicide other_________  method?__________________________
Do you want any information about birth control?  Yes No __________________________________
Date of your last Pap test?_______________
Do you have any questions about safer s e x ?   Yes No ____________________________ _— —
Do you smoke cigarettes?..........................................................  Yes No How many per day?_________________
Do you use street drugs?  Yes No __________________________________
Do you drink alcohol?................................................................. Yes No How often? How much?-----------------------
Have you ever felt the need to cut down on your drinking?. Yes No __________________________ — --------
Are you exercising?.....................................................................  Yes No How often? What type?_____________
Have you had any illnesses?  Yes No ________________________ ___— ------
Have you seen any of your other doctors recently?  Yes No __________________________________
Are you taking any medicines now?............................................ Yes No __________________________ —------—.
Have you ever had a cholesterol test?  Yes No When?______________________ _— —
Please answer If you are over 39:
Date of your last mammogram?___________________
Date of your last stool test?_______________________
What brings you to our office today?
Do you have any questions, problems, or concerns that you would like to discuss with us today?
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Appendix G GYN Cytology Report Form
4̂ %%^GYN ?qYTOLQGY REPORT
Patient: 
Address: 











Number of Slides: 
Clinical History:

















Page: 1 of 1
Date of Specimen: 
Clinical Data:























Random number assigned to case to assure anonymity
Race
Year of Birth
Age at time of first ASCUS 
Date of first ASCUS
Date of last menstrual period at first ASCUS
Coded 1 if ASCUS suggestive of Human PapillomavirusCoded 0 if ASCUS not suggestive of Human Papillomavirus
Coded 1 if genital warts are presentCoded 0 if genital warts are not present
Coded 1 if patient smokesCoded 0 if patient does not smoke




OCP Oral Contraceptive PillsT Tubal SterilizationPM Post-menopausalX/UKN None or unknown NR Natural/rhythmD DiaphragmC CondomsN Norplant
Candida noted on cytology report Coded 1 if present
Herpes Simplex Virus noted on cytology report Coded 1 if present
GonorrheaCoded 1 if identified
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BC Bacteria noted on cytology reportCoded 1 if present
CHL ChlamydiaCoded 1 if identified
BX Date Date of colposcopically directed biopsy
LMP Date of last menstrual period preceding biopsy
DX Diagnosis coded 0 for negative biopsyDiagnosis coded 1 for dysplasia on biopsy
L/H Coded 0 for low grade SILCoded 1 for high grade SIL
BXH Coded 1 for HPV on biopsy
BY Coded 0 or 1 for physician identificationperforming biopsy
PG Coded 0 for not pregnant at time of indexsmearCoded 1 for pregnancy
#AS Number of abnormal cytology reports held bypathology laboratory including index smear before biopsy
ELT Elapsed time in days between index smear andbiopsy
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